Document is current
Any future updates will be listed below
-
Authors
Pollán, M. http://orcid.org/0000-0001-9237-3231
Casla-Barrio, S.
Alfaro, J.
Esteban, C.
Segui-Palmer, M. A.
Lucia, A.
Martín, M.
-
Funding
Funding for this research was provided by:
Spanish Society of Medical Oncology
- License Information
-
More Information
Article History
Received: 14 December 2019
Accepted: 27 January 2020
First Online: 13 February 2020
Compliance with ethical standards
:
: MP declares that she have no conflict of interest; SC declares that she have no conflict of interest; JA received institutional research grants from Merck Serono and Novartis; CE received speaker’s honoraria from AstraZeneca, Roche, Novartis and Pfizer; MAS-P received consulting/advisory fees from AstraZeneca, Pfizer and Amgen, and speakers’ honoraria from Amgen, Roche and Pfizer; AL declares that he have no conflict of interest; MM has received research grants from Roche and Novartis, consulting/advisory fees from AstraZeneca, Amgen, Taiho Oncology, Roche/Genentech, Novartis, PharmaMar, Eli Lilly, PUMA Taiho Oncology and Pfizer, and speakers’ honoraria from AstraZeneca, Amgen, Roche/Genentech, Novartis and Pfizer.
: The manuscript does not contain any studies with human participants or animals performed by any of the authors.
: Informed consent/ethical approval is not required for this type of project.
